Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06051058 · ClinicalTrials.gov registry record · NA
Care Transitions App for Patients With Multiple Chronic Conditions
A NA study of Heart Failure and Diabetes, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 798
- Enrollment target
- 1
- Study location
NCT06051058: Recruiting NA study of Heart Failure and Diabetes, sponsored by Brigham and Women's Hospital.
NCT06051058 is a NA study of Heart Failure and Diabetes that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 798 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06051058, a NA study of Heart Failure and Diabetes, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 798 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to widely implement and evaluate the Care Transitions App in a randomized controlled trial. The app the investigators designed for patients with multiple chronic conditions has four envisioned modules: 1) falls-reduction content, 2) a digital post-discharge transitional care plan (e.g., after hospital care plan, including education, medications, follow-up appointments, warning signs to watch for, nutrition, and other care plan activities), 3) a new module for patients with MCC (diabetes, congestive heart failure, and chronic kidney disease) including condition-specific post-discharge care plans with relevant symptom management activities, 4) a new post-discharge report module which summarizes key care transition findings and allows for patients to enter notes and questions for their providers and their own goals for recovery.
Primary Outcome
Overall rate of post-discharge adverse events
Conditions Studied
Interventions
- BEHAVIORAL Care Transitions App
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 798 participants |
| Start Date | 2024-10-08 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06051058 shows while recruiting
NCT06051058 is an interventional study that assigns participants to a tested intervention. The registered 798 participants enrollment target is mid-sized for trials with a published cap, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (61% lower).
The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Care Transitions App is the first listed.
NCT06051058 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06051058 about?
NCT06051058 is a clinical study titled "Care Transitions App for Patients With Multiple Chronic Conditions". The objective of this study is to widely implement and evaluate the Care Transitions App in a randomized controlled trial. The app the investigators designed for patients with multiple chronic conditions has four envisioned modules: 1) falls-reduction content, 2) a digital post-discharge transitiona...
What is the current status of trial NCT06051058?
This trial is currently recruiting. It is a NA study. The enrollment target is 798 participants. The study started on 2024-10-08. Estimated completion is 2026-12.
What conditions does trial NCT06051058 study?
This clinical trial studies the following conditions: Heart Failure, Diabetes, Diabetes Mellitus, Chronic Kidney Diseases, Congestive Heart Failure.
What interventions are being tested in trial NCT06051058?
The interventions under investigation include: Care Transitions App (BEHAVIORAL).
Who is sponsoring clinical trial NCT06051058?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06051058 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06051058's enrollment target sits among peer trials
798 79th of 397 higher than 319 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI